These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29657012)

  • 21. Babesia canis and Babesia rossi co-infection in an untraveled Nigerian dog.
    Kamani J; Sannusi A; Dogo AG; Tanko JT; Egwu KO; Tafarki AE; Ogo IN; Kemza S; Onovoh E; Shamaki D; Lombin LH; Catto V; Birkenheuer AJ
    Vet Parasitol; 2010 Oct; 173(3-4):334-5. PubMed ID: 20705395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First molecular identification of Babesia gibsoni in dogs from Slovakia, central Europe.
    Víchová B; Horská M; Blaňarová L; Švihran M; Andersson M; Peťko B
    Ticks Tick Borne Dis; 2016 Feb; 7(1):54-59. PubMed ID: 26304014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A SimpleProbe(®) real-time PCR assay for differentiating the cytochrome b M121I mutation in clinical specimens from dogs infected with Babesia gibsoni.
    Liu PC; Lin YL; Lin CN; Su BL
    Ticks Tick Borne Dis; 2016 Jul; 7(5):639-643. PubMed ID: 26874668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microscopic and molecular analysis of Babesia canis in archived and diagnostic specimens reveal the impact of anti-parasitic treatment and postmortem changes on pathogen detection.
    Huber D; Beck A; Anzulović Ž; Jurković D; Polkinghorne A; Baneth G; Beck R
    Parasit Vectors; 2017 Oct; 10(1):495. PubMed ID: 29047398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni.
    Lin EC; Chueh LL; Lin CN; Hsieh LE; Su BL
    Vet Parasitol; 2012 May; 186(3-4):159-64. PubMed ID: 22222008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
    Gray JS; Pudney M
    J Parasitol; 1999 Aug; 85(4):723-8. PubMed ID: 10461956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canine babesiosis: A literature review of prevalence, distribution, and diagnosis in Latin America and the Caribbean.
    Panti-May JA; Rodríguez-Vivas RI
    Vet Parasitol Reg Stud Reports; 2020 Jul; 21():100417. PubMed ID: 32862915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short report: cloning of the Babesia gibsoni cytochrome B gene and isolation of three single nucleotide polymorphisms from parasites present after atovaquone treatment.
    Matsuu A; Miyamoto K; Ikadai H; Okano S; Higuchi S
    Am J Trop Med Hyg; 2006 Apr; 74(4):593-7. PubMed ID: 16606990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and molecular characterization of a novel large Babesia species in a dog.
    Birkenheuer AJ; Neel J; Ruslander D; Levy MG; Breitschwerdt EB
    Vet Parasitol; 2004 Oct; 124(3-4):151-60. PubMed ID: 15381295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of canine babesiosis in South Africa.
    Collett MG
    J S Afr Vet Assoc; 2000 Sep; 71(3):180-6. PubMed ID: 11205168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro screening of novel anti-Babesia gibsoni drugs from natural products.
    Ji S; Liu M; Galon EM; Rizk MA; Li J; Li Y; Zafar I; Igarashi I; Xuan X
    Parasitol Int; 2021 Dec; 85():102437. PubMed ID: 34389492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Efficacy and Safety of Malarone
    Karasová M; Tóthová C; Víchová B; Blaňarová L; Kisková T; Grelová S; Staroňová R; Micháľová A; Kožár M; Nagy O; Fialkovičová M
    Animals (Basel); 2022 Mar; 12(6):. PubMed ID: 35327106
    [No Abstract]   [Full Text] [Related]  

  • 33. Diminazene aceturate and imidocarb dipropionate-based combination therapy for babesiosis - A new paradigm.
    Rizk MA; El-Sayed SAE; Igarashi I
    Ticks Tick Borne Dis; 2023 Jul; 14(4):102145. PubMed ID: 37011497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine babesiosis.
    Schoeman JP
    Onderstepoort J Vet Res; 2009 Mar; 76(1):59-66. PubMed ID: 19967929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs.
    Iguchi A; Matsuu A; Fujii Y; Ikadai H; Hikasa Y
    Vet Parasitol; 2013 Nov; 197(3-4):527-33. PubMed ID: 24075418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Babesia canis infection in canine-red blood cell-substituted SCID mice.
    Arai S; Tsuji M; Kim SJ; Nakade T; Kanno Y; Ishihara C
    Int J Parasitol; 1998 Sep; 28(9):1429-35. PubMed ID: 9770629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine predictors of mortality in canine babesiosis caused by Babesia canis rossi.
    Schoeman JP; Rees P; Herrtage ME
    Vet Parasitol; 2007 Sep; 148(2):75-82. PubMed ID: 17614201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in selected subpopulations of lymphocytes in dogs infected with Babesia canis treated with imidocarb.
    Adaszek Ł; Jarosz Ł; Kalinowski M; Staniec M; Grądzki Z; Salmons B; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2015; 43(2):94-100. PubMed ID: 25771779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of
    Rizk MA; El-Sayed SAE; Alkhoudary MS; Alsharif KF; Abdel-Daim MM; Igarashi I
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An unusual form of canine babesiosis.
    Van de Maele I; Savary-Bataille K; Gielen I; Daminet S
    Can Vet J; 2008 Mar; 49(3):283-6. PubMed ID: 18390102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.